Profile: Sirius Genomics Inc. is a biotechnology company that develops DNA-based diagnostic and pharmacogenetic tests for critical care. We offer products that focus on the development of Dx and PGx tests for sepsis, a systemic blood infection. Our platform can also be applied to previously failed drugs, drugs in clinical trials, and new indications for currently approved drugs.